844 related articles for article (PubMed ID: 17514407)
21. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
[TBL] [Abstract][Full Text] [Related]
22. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
Alvarado R; Yi M; Le-Petross H; Gilcrease M; Mittendorf EA; Bedrosian I; Hwang RF; Caudle AS; Babiera GV; Akins JS; Kuerer HM; Hunt KK
Ann Surg Oncol; 2012 Oct; 19(10):3177-84. PubMed ID: 22772869
[TBL] [Abstract][Full Text] [Related]
23. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
Brady EW
Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
[TBL] [Abstract][Full Text] [Related]
26. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
27. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
[TBL] [Abstract][Full Text] [Related]
28. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
29. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.
Kilbride KE; Lee MC; Nees AV; Cimmino VM; Diehl KM; Sabel MS; Hayes DF; Schott AF; Kleer CG; Chang AE; Newman LA
Ann Surg Oncol; 2008 Nov; 15(11):3252-8. PubMed ID: 18784961
[TBL] [Abstract][Full Text] [Related]
30. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
[TBL] [Abstract][Full Text] [Related]
31. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
32. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.
Wong SM; Weiss A; Mittendorf EA; King TA; Golshan M
Ann Surg Oncol; 2019 Oct; 26(11):3517-3525. PubMed ID: 31342389
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
34. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
[TBL] [Abstract][Full Text] [Related]
35. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
Montagna G; Lee MK; Sevilimedu V; Barrio AV; Morrow M
Ann Surg Oncol; 2022 Oct; 29(10):6133-6139. PubMed ID: 35902495
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
37. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer.
Hino M; Sano M; Sato N; Homma K
Surg Today; 2008; 38(7):585-91. PubMed ID: 18612781
[TBL] [Abstract][Full Text] [Related]
39. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
[TBL] [Abstract][Full Text] [Related]
40. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
